 |
PDBsum entry 7ujy
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transcription
|
PDB id
|
|
|
|
7ujy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transcription
|
 |
|
Title:
|
 |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time
|
|
Structure:
|
 |
Estrogen receptor. Chain: b, a, c, d. Synonym: er,er-alpha,estradiol receptor,nuclear receptor subfamily 3 group a member 1. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: esr1, esr, nr3a1. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
1.70Å
|
R-factor:
|
0.190
|
R-free:
|
0.224
|
|
|
Authors:
|
 |
D.J.Hosfield,G.L.Greene,S.W.Fanning
|
|
Key ref:
|
 |
D.J.Hosfield
et al.
(2022).
Stereospecific lasofoxifene derivatives reveal the in between estrogen receptor alpha stability and antagon activity in esr1 mutant breast cancer cells..
Elife,
11,
.
PubMed id:
|
 |
|
Date:
|
 |
|
31-Mar-22
|
Release date:
|
15-Jun-22
|
|
|
Supersedes:
|
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
');
}
}
 |
|